263 related articles for article (PubMed ID: 25687586)
1. Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds.
Harada S; Hiromori Y; Nakamura S; Kawahara K; Fukakusa S; Maruno T; Noda M; Uchiyama S; Fukui K; Nishikawa J; Nagase H; Kobayashi Y; Yoshida T; Ohkubo T; Nakanishi T
Sci Rep; 2015 Feb; 5():8520. PubMed ID: 25687586
[TBL] [Abstract][Full Text] [Related]
2. Organotin compounds cause structure-dependent induction of progesterone in human choriocarcinoma Jar cells.
Hiromori Y; Yui H; Nishikawa J; Nagase H; Nakanishi T
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):190-8. PubMed ID: 25465476
[TBL] [Abstract][Full Text] [Related]
3. Transactivation of the human retinoid X receptor by organotins: use of site-directed mutagenesis to identify critical amino acid residues for organotin-induced transactivation.
Hiromori Y; Aoki A; Nishikawa J; Nagase H; Nakanishi T
Metallomics; 2015 Jul; 7(7):1180-8. PubMed ID: 25985376
[TBL] [Abstract][Full Text] [Related]
4. Structure-dependent activation of peroxisome proliferator-activated receptor (PPAR) gamma by organotin compounds.
Hiromori Y; Nishikawa J; Yoshida I; Nagase H; Nakanishi T
Chem Biol Interact; 2009 Jul; 180(2):238-44. PubMed ID: 19497422
[TBL] [Abstract][Full Text] [Related]
5. Organotin compounds act as inhibitor of transcriptional activation with human estrogen receptor.
Cho EM; Lee HS; Moon JS; Kim IS; Sim S; Ohta A
J Microbiol Biotechnol; 2012 Mar; 22(3):378-84. PubMed ID: 22450794
[TBL] [Abstract][Full Text] [Related]
6. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates.
Grün F; Watanabe H; Zamanian Z; Maeda L; Arima K; Cubacha R; Gardiner DM; Kanno J; Iguchi T; Blumberg B
Mol Endocrinol; 2006 Sep; 20(9):2141-55. PubMed ID: 16613991
[TBL] [Abstract][Full Text] [Related]
7. Potent inhibition of tributyltin (TBT) and triphenyltin (TPT) against multiple UDP-glucuronosyltransferases (UGT): A new potential mechanism underlying endocrine disrupting actions.
Lv H; Wang J; Wang M; Shen L; Xiao L; Chen T; Sun T; Li W; Zhu L; Zhang X
Food Chem Toxicol; 2021 Mar; 149():112039. PubMed ID: 33549631
[TBL] [Abstract][Full Text] [Related]
8. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
Waku T; Shiraki T; Oyama T; Fujimoto Y; Maebara K; Kamiya N; Jingami H; Morikawa K
J Mol Biol; 2009 Jan; 385(1):188-99. PubMed ID: 18977231
[TBL] [Abstract][Full Text] [Related]
9. Endocrine disruption induced by organotin compounds; organotins function as a powerful agonist for nuclear receptors rather than an aromatase inhibitor.
Nakanishi T
J Toxicol Sci; 2008 Aug; 33(3):269-76. PubMed ID: 18670157
[TBL] [Abstract][Full Text] [Related]
10. Tributyltin and triphenyltin exposure promotes in vitro adipogenic differentiation but alters the adipocyte phenotype in rainbow trout.
Lutfi E; Riera-Heredia N; Córdoba M; Porte C; Gutiérrez J; Capilla E; Navarro I
Aquat Toxicol; 2017 Jul; 188():148-158. PubMed ID: 28527383
[TBL] [Abstract][Full Text] [Related]
11. Activation of RXR-PPAR heterodimers by organotin environmental endocrine disruptors.
le Maire A; Grimaldi M; Roecklin D; Dagnino S; Vivat-Hannah V; Balaguer P; Bourguet W
EMBO Rep; 2009 Apr; 10(4):367-73. PubMed ID: 19270714
[TBL] [Abstract][Full Text] [Related]
12. Organotin mixtures reveal interactions that modulate adipogenic differentiation in 3T3-L1 preadipocytes.
Ticiani E; Pu Y; White M; Adomshick V; Veiga-Lopez A
Arch Toxicol; 2023 Jun; 97(6):1649-1658. PubMed ID: 37142754
[TBL] [Abstract][Full Text] [Related]
13. Molecular targets of organotin compounds in endocrine disruption: do organotin compounds function as aromatase inhibitors in mammals?
Nakanishi T; Nishikawa J; Tanaka K
Environ Sci; 2006; 13(2):89-100. PubMed ID: 16788560
[TBL] [Abstract][Full Text] [Related]
14. Tributyltin and triphenyltin inhibit osteoclast differentiation through a retinoic acid receptor-dependent signaling pathway.
Yonezawa T; Hasegawa S; Ahn JY; Cha BY; Teruya T; Hagiwara H; Nagai K; Woo JT
Biochem Biophys Res Commun; 2007 Mar; 355(1):10-5. PubMed ID: 17291456
[TBL] [Abstract][Full Text] [Related]
15. Organotins are potent activators of PPARγ and adipocyte differentiation in bone marrow multipotent mesenchymal stromal cells.
Yanik SC; Baker AH; Mann KK; Schlezinger JJ
Toxicol Sci; 2011 Aug; 122(2):476-88. PubMed ID: 21622945
[TBL] [Abstract][Full Text] [Related]
16. Structurally-diverse, PPARγ-activating environmental toxicants induce adipogenesis and suppress osteogenesis in bone marrow mesenchymal stromal cells.
Watt J; Schlezinger JJ
Toxicology; 2015 May; 331():66-77. PubMed ID: 25777084
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators.
Hamuro Y; Coales SJ; Morrow JA; Molnar KS; Tuske SJ; Southern MR; Griffin PR
Protein Sci; 2006 Aug; 15(8):1883-92. PubMed ID: 16823031
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of retinoid X receptor with an emphasis on the mediation of organotin poisoning in the Pacific oyster (Crassostrea gigas).
Huang W; Wu Q; Xu F; Li L; Li J; Que H; Zhang G
Gene; 2020 Aug; 753():144780. PubMed ID: 32439374
[TBL] [Abstract][Full Text] [Related]
19. Atomic structure of mutant PPARgamma LBD complexed with 15d-PGJ2: novel modulation mechanism of PPARgamma/RXRalpha function by covalently bound ligands.
Waku T; Shiraki T; Oyama T; Morikawa K
FEBS Lett; 2009 Jan; 583(2):320-4. PubMed ID: 19101554
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for differential activities of enantiomeric PPARγ agonists: Binding of S35 to the alternate site.
Jang JY; Koh M; Bae H; An DR; Im HN; Kim HS; Yoon JY; Yoon HJ; Han BW; Park SB; Suh SW
Biochim Biophys Acta Proteins Proteom; 2017 Jun; 1865(6):674-681. PubMed ID: 28342850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
